Andy Extance charts how research into revolutionary targeted protein degradation therapies is moving from serendipity to ...

A tunnel along the border wall in Texas, going from Mexico into the U.S. and believed to have been used by smugglers, was ...

Absci recently received a $20 million PIPE investment from AMD that improves its runway and R&D platform with AI. See why I ...

Allison Holker, the wife of the late Stephen "tWitch" Boss" details the discovery of a secret drug stash she found after his ...

Telix Pharmaceuticals Ltd (ASX:TLX) is adding to its portfolio of early-stage drug candidates, in addition to a suite of ...

Telix Pharmaceuticals (ASX:TLX) enters into an asset purchase agreement with antibody engineering company ImaginAb.

Life sciences have always been about breakthroughs, but the pandemic revealed a sobering truth: speed and scale are the ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

Over a video call, Alex Zhavoronkov holds up a small, green, diamond-shaped pill. It has been developed by his company to ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...